Recombinant Rabbit Prolactin receptor (PRLR)

Shipped with Ice Packs
In Stock

Description

Introduction and Overview

Recombinant Rabbit Prolactin Receptor (PRLR) is a synthetic, non-glycosylated protein engineered to mimic the extracellular domain (ECD) of the native rabbit prolactin receptor. It belongs to the class I cytokine receptor family and plays a critical role in mediating prolactin (PRL)-induced signaling pathways, including JAK2-STAT5, PI3K/Akt, and MAPK cascades . This recombinant form is produced in Escherichia coli and is widely used in research to study PRLR-ligand interactions, signaling mechanisms, and therapeutic applications .

Production and Biochemical Properties

Recombinant rabbit PRLR is produced via bacterial expression systems, followed by purification using methods like nickel-affinity chromatography (for His-tagged variants) or proprietary chromatographic techniques .

PropertyDetailsSource
Molecular Mass23–24 kDa
Purity>97% (SDS-PAGE, HPLC)
Endotoxin<0.1 ng/µg (<1 EU/µg)
FormulationLyophilized powder reconstituted in sterile water (100 µg/ml–1 mg/ml)
StabilityStable at -18°C; avoid freeze-thaw cycles to prevent oligomerization

Functional and Biological Activity

Recombinant rabbit PRLR-ECD is functionally validated through:

  • Ligand Binding: Forms a 1:1 complex with rabbit prolactin (rbPRL) and other lactogenic hormones (e.g., ovine PRL) .

  • Biological Assays:

    • Nb2 Cell Proliferation Inhibition: Dose-dependent inhibition of PRL-stimulated Nb2 cell growth .

    • Signal Transduction: Activation of JAK2-STAT5, PI3K/Akt, and MAPK pathways in transfected cells .

AssayOutcomeSource
Nb2 Cell ProliferationInhibition of PRL-induced growth (EC₅₀ ~1–10 nM)
Binding AffinityHigh-affinity interaction with rbPRL (Kd ~10⁻⁹ M)

Comparative Analysis with Other Receptors

Recombinant rabbit PRLR differs from human and rodent receptors in its binding kinetics and signaling efficiency. For example:

  • Species-Specific Activity: Rabbit PRL exhibits 4–8-fold lower activity compared to human PRL in Nb2 and Baf3 cell assays .

  • Domain Variability: The cytoplasmic domain length (absent in recombinant ECD) modulates ligand binding and signal transduction in native receptors .

Mechanistic Studies

  • Signaling Pathways: Recombinant PRLR is used to dissect PRL-induced JAK2-STAT5 activation in breast cancer cells .

  • Receptor Dimerization: The ECD’s D1 and D2 subdomains are critical for PRL-induced receptor dimerization and signaling .

Therapeutic Targets

  • Cancer Research: Overexpression of PRLR in breast cancer correlates with tumor progression, making it a potential therapeutic target .

  • Reproductive Biology: PRLR-ECD inhibits PRL signaling in ovarian granulosa cells, influencing follicular development .

Comparative Studies

ParameterRecombinant PRLRNative PRLR
GlycosylationAbsentPresent (cell surface)
SolubilityHigh (ECD-focused)Membrane-bound
Signaling EfficiencyPartial (ECD-only)Full (ICD-dependent)

Challenges and Considerations

  • Functional Limitations: The absence of the intracellular domain restricts full signal transduction studies .

  • Species Variability: Cross-reactivity with non-rabbit PRLR antibodies (e.g., human-specific clones) is limited .

  • Storage Handling: Lyophilized PRLR requires strict storage at -18°C to prevent oligomerization .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C; lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
PRLR; Prolactin receptor; PRL-R
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
25-616
Protein Length
Full Length of Mature Protein
Species
Oryctolagus cuniculus (Rabbit)
Target Names
Target Protein Sequence
QSPPGKPFIFKCRSPEKETFTCWWRPGADGGLPTNYTLTYHKEGETITHECPDYKTGGPNSCYFSKKHTSIWTIYIITVNATNQMGSSVSDPRYVDVTYIVEPDPPVNLTLEVKHPEDRKPYLWVKWLPPTLVDVRSGWLTLQYEIRLKPEKAAEWETHFAGQQTQFKILSLYPGQKYLVQVRCKPDHGFWSVWSPESSIQIPNDFTMKDITVWIFVAVLSTIICLIMVWAVALKGYSMVTCIFPPVPGPKIKGFDTHLLEKGKSEELLSAFGCQDFPPTADCEDLLVEFLEVDDSEDQQLMPAHSKEHSGPGMKPTDLDPDNDSGRGSCDSPSLLSEKCEEPQANPSTFHTPEVIEQPEKPKANVTHTWDPQTISLVGKMPYLSVNGSKSSTWPLLQPGQHNTNSPYHNIADMCKLATSLDKIDKDALQSSKTTEAAGEEKATKQREVESSHSKAEQDTGWLLPKEKPPFISPKPLDYVEIHKVNKDGALSLLLKQKENGDQTGKAGTPETSKEYAKVSRVMDNNILVLVQDPGAQNVALFEESTKEAPPSPSQNQAEKDLSSFSTAPSDCRLQQGGLDYLDPACFMHSLH
Uniprot No.

Target Background

Function

This protein is a receptor for prolactin, a hormone produced by the anterior pituitary gland.

Database Links
Protein Families
Type I cytokine receptor family, Type 1 subfamily
Subcellular Location
Membrane; Single-pass type I membrane protein.

Q&A

What are the key structural features of recombinant rabbit PRLR?

Rabbit PRLR is a membrane protein primarily involved in mammary gland development and lactation. The full-length recombinant rabbit PRLR has a molecular mass of approximately 94 kDa, which corresponds to the translation product of the entire cDNA coding region. Interestingly, the receptor biochemically identified in the rabbit mammary gland is much shorter, suggesting that the receptor undergoes post-translational modifications in vivo .

Several recombinant forms of rabbit PRLR can be produced:

  • Full-length receptor forms (L1, L2): Associated with the membrane fraction

  • Truncated membrane form (S): Retains membrane association

  • Secretable form of the extracellular domain (E): Predominantly secreted into medium

  • Intracellular domain forms (I1, I2): Expressed as soluble proteins, with a significant portion accumulating in culture medium

How does rabbit prolactin (rbPRL) interact with its receptor compared to other species?

Rabbit prolactin exhibits lower binding affinity to its homologous receptor compared to other species' PRLs (such as ovine PRL). This difference is attributed to its faster and more complete dissociation kinetics . The binding potency of recombinant rbPRL to its receptor varies based on where the receptor is expressed:

Receptor Expression SystemRelative Binding Potency
Endogenous (mammary gland)One log unit lower than with other species
Recombinant in mammalian cellsOne log unit lower than with other species
Recombinant in insect cellsHigher affinity than above systems

This variation in binding potency is likely related to cell-dependent receptor densities .

What experimental methods can verify proper folding of recombinant rabbit PRLR?

Verification of proper folding and functionality of recombinant rabbit PRLR can be assessed through multiple complementary approaches:

  • Circular dichroism (CD) spectroscopy: Comparing spectral characteristics with native PRLR

  • Binding parameter analysis: Assessing affinity constants and binding kinetics

  • Bioactivity assays: Measuring functional responses such as:

    • Proliferation induction in receptor-expressing cells

    • Activation of downstream signaling pathways (e.g., STAT5 phosphorylation)

    • Complex formation with ligands (rbPRL forms 1:1 complex with rabbit PRLR-ECD)

These methodologies ensure that the recombinant receptor maintains native conformation and biological functionality.

What expression systems are optimal for producing functional recombinant rabbit PRLR?

Several expression systems have been successfully employed for rabbit PRLR production, each with distinct advantages:

Expression SystemAdvantagesConsiderations
Insect/baculovirusProduces large amounts of various PRLR forms; Suitable for full-length receptor (L1, L2), truncated forms (S), and extracellular domain (E)Post-translational modifications differ from mammalian systems
Mammalian cells (e.g., HEK 293)More native-like post-translational modifications; Suitable for stable transfectionLower yields than insect systems; Requires antibiotic selection
E. coli (for ligand production)High yield of rbPRL; Cost-effectiveProduces inclusion bodies requiring refolding; Limited post-translational modifications

For functional studies, the insect/baculovirus expression system has proven particularly effective for producing multiple recombinant forms of rabbit PRLR in large quantities while maintaining their ligand-binding capabilities .

What purification strategies yield the highest quality recombinant rabbit PRLR?

Optimal purification strategies depend on the expression system and specific form of PRLR:

  • For tagged PRLR constructs:

    • Ni-affinity chromatography for His-tagged proteins yields high purity (>98%)

    • Immunoaffinity chromatography using anti-receptor antibodies for native conformation

  • For untagged or native-like PRLR:

    • Sequential chromatography techniques:
      a. Ion-exchange chromatography
      b. Size exclusion chromatography
      c. Affinity chromatography using ligand (PRL) as bait

  • Quality assessment criteria:

    • Purity assessment via SDS-PAGE and HPLC (target >98%)

    • Western blotting using specific antibodies (e.g., anti-human PRLR 1A2B1)

    • Mass spectrometry confirmation of identity and integrity

How can recombinant rabbit PRLR be used to study receptor dimerization and activation?

Recombinant rabbit PRLR provides an excellent model for investigating receptor dimerization and activation mechanisms through several advanced techniques:

  • FRET (Fluorescence Resonance Energy Transfer):

    • Generate PRLR constructs tagged with appropriate fluorophores

    • Monitor conformational changes upon ligand binding

    • Can be combined with TR-FRET (Time-Resolved FRET) for improved signal-to-noise ratio

  • BRET (Bioluminescence Resonance Energy Transfer):

    • Complementary to FRET analysis for studying protein-protein interactions

    • Useful for real-time monitoring in living cells

  • Co-immunoprecipitation assays:

    • Using specific antibodies (e.g., anti-HA at 0.8 μg/mL for IP)

    • Detect receptor-receptor or receptor-effector interactions

  • Native electrophoresis:

    • Analyze oligomeric states of the receptor under non-denaturing conditions

    • Compare receptor conformations with and without ligand binding

These methodologies have revealed that the hormone binding site is located in the extracellular domain, which can function autonomously as a PRL-binding soluble protein .

What are the critical differences between recombinant and native rabbit PRLR in experimental systems?

Understanding the differences between recombinant and native forms is crucial for experimental interpretation:

  • Post-translational modifications:

    • The full-length recombinant receptor (94 kDa) differs from the native receptor in mammary tissue, which undergoes extensive post-translational processing

    • These differences may affect ligand recognition, binding kinetics, and signaling

  • Conformation and ligand binding:

    • The soluble extracellular domain (E form) binds prolactin with higher affinity than the native receptor

    • E form does not bind one of the two anti-receptor monoclonal antibodies specific to the hormone binding site

    • This suggests conformational differences between native and recombinant forms

  • Functional consequences:

    • Variations in binding affinity can impact downstream signaling

    • Proliferation activity is sensitive to PRLR-ligand affinity and dissociation kinetics

    • Differentiation responses may be less affected by these differences

How do experimental conditions affect rabbit PRLR-mediated signaling pathways?

The experimental context significantly influences PRLR signaling outcomes:

  • Cell type-dependent effects:

    • Receptor density varies between expression systems, affecting binding potency

    • Endogenous vs. recombinant expression systems show one log unit difference in binding affinities

  • Receptor form-dependent signaling:

    • Full-length (L1, L2) vs. truncated (S) forms may activate different signaling cascades

    • The intracellular domain forms (I1, I2) do not bind prolactin but may still affect signaling

  • Ligand-specific responses:

    • Recombinant rbPRL induces different gene expression patterns compared to native PRL:

      • rPRL upregulates anti-apoptotic Bcl2 expression

      • Native PRL inhibits Bcl2 expression and promotes Caspase3 and Fas expression

      • Both forms reduce Beclin1 mRNA levels

These variations highlight the importance of carefully designing experiments and selecting appropriate models when studying PRLR function.

What strategies can address poor expression or misfolding of recombinant rabbit PRLR?

When encountering expression or folding challenges with recombinant rabbit PRLR:

  • Expression optimization:

    • Adjust induction conditions (temperature, time, inducer concentration)

    • Optimize codon usage for the expression system

    • Co-express chaperones to assist with folding

    • Use fusion tags that enhance solubility (e.g., SUMO, thioredoxin)

  • Refolding techniques for inclusion bodies:

    • Gradual dilution to prevent aggregation

    • Step-wise dialysis to remove denaturants

    • Use of stabilizing agents during refolding

    • Assess proper renaturation by comparing CD spectra, binding parameters, and bioactivity with native protein

  • Quality control assessment:

    • Verify receptor integrity using SDS-PAGE and HPLC (target >98% purity)

    • Confirm proper folding through binding to specific monoclonal antibodies (M110, A917) that recognize native conformation

    • Test functionality using prolactin-binding assays

How can researchers accurately measure binding kinetics between rabbit prolactin and its receptor?

Measuring binding kinetics requires precise methodologies:

  • Surface Plasmon Resonance (SPR):

    • Immobilize receptor or ligand on sensor chip

    • Measure real-time association and dissociation rates

    • Calculate binding constants (Ka, Kd, KD)

  • Radioligand binding assays:

    • Use iodinated prolactin with consistent specific activity

    • Perform saturation binding to determine Bmax and KD

    • Conduct competition binding with unlabeled ligands

    • Analyze association/dissociation kinetics

  • Fluorescence-based methods:

    • Prepare labeled hormones (e.g., with Red fluorophore using d2 labeling kit)

    • Assess bioactivity of labeled proteins using reporter gene assays

    • Optimize labeling to maintain native binding properties

    • Note that high levels of fluorophore may slightly reduce bioactivity

  • Bioactivity correlation:

    • Compare binding assays with functional readouts:

      • Proliferation assays: rbPRL shows one log unit lower proliferation potency compared to oPRL, consistent with its lower binding affinity

      • Differentiation assays: Potencies are similar despite binding differences

What cellular models are most appropriate for studying rabbit PRLR function?

Selection of appropriate cellular models is critical for studying rabbit PRLR:

  • Established cell lines:

    • Nb2 cells: Highly sensitive to prolactin, useful for bioactivity assays

    • Baf3 cells stably transfected with rabbit prolactin receptor: Enables species-specific studies

    • HEK 293 cells: Suitable for stable expression of recombinant PRLR

  • Generation of stable expressing cell lines:

    • Co-transfect PRLR constructs with antibiotic resistance genes (e.g., pcDNA3.1 with geneticin resistance)

    • Use optimal DNA ratios (10:1 recommended)

    • Select with appropriate antibiotic concentration (e.g., 500 μg/mL Geneticin)

    • Characterize clones for PRLR expression and PRL-responsiveness

    • Create different expression level clones (e.g., "PRLR high" or "PRLR low")

  • Primary cell models:

    • Mammary epithelial cells: Physiologically relevant context

    • Lacrimal acinar cells: Useful for studying secretory pathway effects

  • Functional validation:

    • Verify receptor functionality through:

      • STAT5 phosphorylation assays

      • Reporter gene activation (e.g., LHRE-luciferase)

      • Proliferation or differentiation responses

How can recombinant rabbit PRLR be utilized to study intracellular trafficking and secretory pathways?

Recombinant rabbit PRLR provides valuable insights into protein trafficking:

  • Vesicular transport studies:

    • AdPRL (adenovirus vector for rabbit PRL) affects secretory protein traffic without disrupting cytoskeletal structures

    • Redirects vesicle transport from apical to basal-lateral membrane in polarized cells

    • Changes polarized distributions of vesicles containing rab3D and syncollin-GFP

  • Experimental approaches:

    • Live-cell imaging with fluorescently tagged constructs

    • Co-localization with vesicle markers

    • Pulse-chase experiments to track protein movement

    • Utilization of trafficking inhibitors to identify specific pathways

  • Physiological relevance:

    • Elevated PRL induces lacrimal epithelial cells to express a mixed exocrine/endocrine phenotype

    • Alters secretory protein traffic without affecting total secretion

    • May provide insights into secretory changes during physiological hyperprolactinemia (e.g., pregnancy)

What are the species-specific differences in PRLR function and how can they be experimentally addressed?

Understanding species differences requires comparative approaches:

  • Binding affinity variations:

    • Rabbit PRL shows lower affinity for its receptor compared to other species

    • Binding potency of recombinant rbPRL is 8-fold lower with Nb2 cells and 4-fold lower with Baf3 cells expressing rabbit PRLR compared to human PRL

  • Experimental design for comparative studies:

    • Express receptors from different species in the same cellular background

    • Use chimeric receptors to identify domains responsible for species differences

    • Compare binding kinetics (association/dissociation rates) across species

    • Correlate binding with downstream signaling activation

  • Functional consequences:

    • Proliferation potency correlates with binding affinity (one log unit lower for rabbit)

    • Differentiation potency shows less species-specific variation

    • These differences suggest distinct mechanisms for proliferation and differentiation responses

How can structural biology approaches enhance our understanding of rabbit PRLR function?

Advanced structural techniques offer deeper insights:

  • X-ray crystallography:

    • Determine atomic resolution structures of:

      • Rabbit PRLR extracellular domain

      • PRLR-PRL complexes

      • Full-length receptor (challenging but valuable)

  • Cryo-electron microscopy:

    • Visualize membrane-embedded receptor

    • Capture different conformational states

    • Study larger complexes with signaling partners

  • Nuclear Magnetic Resonance (NMR):

    • Analyze dynamic properties and conformational changes

    • Study smaller domains or extracellular fragments

    • Investigate ligand-receptor interactions in solution

  • Computational approaches:

    • Molecular dynamics simulations to study:

      • Conformational flexibility

      • Binding mechanisms

      • Dimerization processes

    • Homology modeling based on related receptors

    • Structure-based drug design for receptor modulators

These structural approaches would help explain the observed differences in binding affinity and signaling between rabbit PRLR and other species, potentially revealing unique structural features that influence its function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.